IP Library › Assignment 054118/0751
Patent Assignment
Reel/Frame 054118/0751

Release of First Lien Security Interest

Recorded: 2020-10-19 Pages: 12
Assignor
JPMORGAN CHASE BANK, N.A.
Executed: 2020-10-19
Assignees
VECTOR LABORATORIES, INC.
30 INGOLD ROAD, BURLINGAME, CALIFORNIA, 94010
TRILINK BIOTECHNOLOGIES, LLC
10770 WATERIDGE CIRCLE, SUITE 200, SAN DIEGO, CALIFORNIA, 92121
GLEN RESEARCH, LLC
22825 DAVIS DRIVE, SUITE 100, STERLING, VIRGINIA, 20164
Covered Properties (21)
Functional Biopolymer Modification Reagents and Uses Thereof
Patent: 7,102,024 →
Application: 09/630,060 →
Triphosphate Oligonucleotide Modification Reagents and Uses Thereof
Patent: 6,686,461 →
Application: 09/630,627 →
Hydrazine-Based and Carbonyl-Based Bifunctional Crosslinking Reagents
Patent: 6,800,728 →
Application: 09/815,978 →
Publication: US 2003/0013857
Pre-activated carbonyl linkers for the modification of Oligonucleotides
Patent: 6,320,041 →
Application: 09/834,828 →
Universal Supports for Oligonucleotide Synthesis
Patent: 6,770,754 →
Application: 09/995,785 →
Publication: US 2002/0137855
Biomolecule/Polymer Conjugates
Patent: 6,911,535 →
Application: 10/050,277 →
Publication: US 2002/0146504
Fluorescent Nitrogenous Base and Nucleosides Incorporating Same
Patent: 7,144,995 →
Application: 10/382,754 →
Publication: US 2004/0009933
Triphosphate Oligonucleotide Modification Reagents and Uses Thereof
Patent: 7,173,125 →
Application: 10/720,840 →
Publication: US 2004/0214199
Hydrazine-Based and Carbonyl-Based Bifunctional Crosslinking Reagents
Patent: 7,462,689 →
Application: 10/720,843 →
Publication: US 2004/0110730
Universal Supports for Oligonucleotide Synthesis
Patent: 7,491,817 →
Application: 10/851,289 →
Publication: US 2005/0250116
Functional Biopolymer Modification Reagents and Uses Thereof
Patent: 7,732,628 →
Application: 10/936,751 →
Publication: US 2005/0203289
Triphosphate Oligonucleotide Modification Reagents and Uses Thereof
Patent: 7,999,098 →
Application: 11/638,062 →
Publication: US 2007/0179288
Phosphotriester-Modified Oligonucleotide Primers for Nucleic Acid Amplification
Patent: 8,361,753 →
Application: 11/750,237 →
Publication: US 2007/0281308
Novel Hydrazone-Based and Oxime-Based Fluorescent and Chromophoric/Pro-Fluorescent and Pro-Chromophoric Reagents and Linkers
Patent: 8,541,555 →
Application: 11/787,932 →
Publication: US 2008/0221343
Chemically Modified Nucleoside 5'-Triphosphates for Thermally Initiated Amplification of Nucleic Acid
Patent: 8,133,669 →
Application: 12/470,449 →
Publication: US 2010/0003724
Chemically Modified Ligase Cofactors, Donors and Acceptors
Patent: 8,728,725 →
Application: 12/831,212 →
Publication: US 2011/0008788
Novel Reagents Utilizing A Serinol Scaffold For Labeling Synthetic Oligonucleotides
Patent: 8,394,948 →
Application: 12/891,888 →
Publication: US 2011/0077389
Functional Biopolymer Modification Reagents and Uses Thereof
Patent: 46,171 →
Application: 13/491,563 →
Preparation and/or Purification of Oligonucleotide Conjugates
Patent: 8,846,875 →
Application: 13/578,752 →
Publication: US 2013/0041140
Chemically Modified Ligase Cofactors, Donors and Acceptors
Patent: 9,631,227 →
Application: 13/833,600 →
Publication: US 2014/0323354
Chemically Modified Ligase Cofactors, Donors and Acceptors
Application: 15/495,848 →
Publication: US 2017/0275672
Related Assignments (25)
Other recorded transfers of the patents in this record — the chain of ownership.
Security Interest Jul 15, 2013
From: SOLULINK INCORPORATED
To: PLYMOUTH MANAGEMENT COMPANY, AS AGENT AND WALTER R. YOUNG, JR., AS AGENT
Reel/Frame 030839/0673 →
Assignment of Assignor's Interest Feb 26, 2014
From: PAUL, NATASHA; SHUM, JONATHAN; LEBEDEV, ALEXANDRE; ZON, GERALD
To: TRILINK BIOTECHNOLOGIES
Reel/Frame 032303/0295 →
Assignment of Assignor's Interest Dec 5, 2015
From: PLYMOUTH MANAGEMENT COMPANY; YOUNG, WALTER R.
To: SOLULINK, INCORPORATED
Reel/Frame 037218/0243 →
Assignment of Assignor's Interest Mar 21, 2016
From: SCHWARTZ, DAVID A.; HOGREFE, RICHARD I.
To: SOLULINK, INCORPORATED
Reel/Frame 038055/0403 →
Assignment of Assignor's Interest Dec 15, 2016
From: SCHWARTZ, DAVID A.; HOGREFE, RICHARD I.
To: SOLULINK, INCORPORATED
Reel/Frame 040638/0371 →
Assignment of Assignor's Interest Dec 17, 2016
From: SCHWARTZ, DAVID A.
To: SOLULINK, INCORPORATED
Reel/Frame 040653/0626 →
Corrective Assignment to Correct the Assignee Name Previously Recorded on Reel 021794 Frame 0324. Assignor(S) Hereby Confirms the Assignment. Dec 17, 2016
From: SCHWARTZ, DAVID A.; HOGREFE, RICHARD I.
To: SOLULINK, INCORPORATED
Reel/Frame 041026/0802 →
Corrective Assignment to Correct the Assignee Is Solulink, Incorporate as Stated on Assignment and Cover Sheet, Not Solulink Biosciences, Inc. as Recorded Previously Recorded on Reel 021798 Frame 0295. Assignor(S) Hereby Confirms the Assignment. Dec 17, 2016
From: SCHWARTZ, DAVID A.; HOGREFE, RICHARD I.
To: SOLULINK, INCORPORATED
Reel/Frame 041001/0907 →
Corrective Assignment to Correct the Assignee Previously Recorded at Reel: 021878 Frame: 0227. Assignor(S) Hereby Confirms the Assignment. Dec 19, 2016
From: SCHWARTZ, DAVID A.; MENDOZA, LEOPOLDO
To: SOLULINK, INCORPORATED
Reel/Frame 041011/0773 →
Security Interest Dec 28, 2016
From: TRILINK BIOTECHNOLOGIES, LLC
To: NXT CAPITAL, LLC, AS AGENT
Reel/Frame 040791/0639 →
Assignment of Assignor's Interest Dec 30, 2016
From: SOLULINK INCORPORATED
To: TRILINK BIOTECHNOLOGIES, LLC
Reel/Frame 040810/0576 →
Release of Security Interests Recorded at Reel/Frame 027370/0349, Reel/Frame 030839/0673 and Reel/Frame 037218/0243 Dec 30, 2016
From: PLYMOUTH MANAGEMENT COMPANY; YOUNG, WALTER R, JR
To: SOLULINK INCORPORATED
Reel/Frame 041225/0221 →
Security Interest Feb 16, 2017
From: TRILINK BIOTECHNOLOGIES, LLC
To: NXT CAPITAL, LLC, AS AGENT
Reel/Frame 041277/0753 →
Security Interest Dec 1, 2017
From: GLEN RESEARCH, LLC
To: NXT CAPITAL, LLC, AS AGENT
Reel/Frame 044275/0032 →
Security Agreement Aug 2, 2018
From: TRILINK BIOTECHNOLOGIES; TRILINK BIOTECHNOLOGIES, INC.; TRILINK BIOTECHNOLOGIES, LLC; GLEN RESEARCH CORPORATION
To: JPMORGAN CHASE BANK, N.A., AS COLLATERAL AGENT
Reel/Frame 046708/0095 →
Security Agreement Aug 3, 2018
From: TRILINK BIOTECHNOLOGIES; TRILINK BIOTECHNOLOGIES, INC.; TRILINK BIOTECHNOLOGIES, LLC; GLEN RESEARCH CORPORATION
To: ANTARES CAPITAL LP, AS COLLATERAL AGENT
Reel/Frame 046702/0651 →
Release and Reassignment of Security Interest Recorded at Reel/Frame 41277/0753 Sep 13, 2018
From: NXT CAPITAL, LLC
To: TRILINK BIOTECHNOLOGIES, LLC
Reel/Frame 047089/0675 →
Release and Reassignment of Security Interest Recorded at Reel/Frame 40791/0639 Sep 13, 2018
From: NXT CAPITAL, LLC
To: TRILINK BIOTECHNOLOGIES, LLC
Reel/Frame 047073/0142 →
Release and Reassignment of Security Interest Recorded at Reel/Frame 44275/0032 Sep 13, 2018
From: NXT CAPITAL, LLC
To: GLEN RESEARCH, LLC
Reel/Frame 047073/0116 →
Entity Conversion Oct 16, 2020
From: GLEN RESEARCH CORPORATION
To: GLEN RESEARCH, LLC
Reel/Frame 054094/0001 →
Release of Second Lien Security Interest Oct 19, 2020
From: ANTARES CAPITAL LP
To: VECTOR LABORATORIES, INC.; TRILINK BIOTECHNOLOGIES, LLC; GLEN RESEARCH, LLC
Reel/Frame 054118/0763 →
Security Agreement Oct 19, 2020
From: MARAVAI LIFE SCIENCES, INC.; TRILINK BIOTECHNOLOGIES, LLC; VECTOR LABORATORIES, INC.; GLEN RESEARCH, LLC
To: MORGAN STANLEY SENIOR FUNDING, INC.
Reel/Frame 054118/0848 →
Partial Release of Security Interest Sep 2, 2021
From: MORGAN STANLEY SENIOR FUNDING, INC.
To: VECTOR LABORATORIES, INC.; TRILINK BIOTECHNOLOGIES, LLC
Reel/Frame 057480/0783 →
Security Interest Oct 7, 2021
From: VECTOR LABORATORIES, INC.
To: AUDAX PRIVATE DEBT LLC, AS AGENT
Reel/Frame 057729/0126 →
Assignment of Assignor's Interest Oct 8, 2021
From: TRILINK BIOTECHNOLOGIES, LLC
To: VECTOR LABORATORIES, INC.
Reel/Frame 057742/0627 →